Shareholders' Equity |
3 Months Ended | ||||||
|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||
| Equity [Abstract] | |||||||
| Shareholders' Equity |
Since the inception of the Company's stock repurchase plan in 2004 through March 31, 2022, the Company's Board of Directors has authorized the repurchase of $1.5 billion of the Company's common stock. Shares of the Company's common stock may be purchased in the open market or through privately negotiated transactions, subject to market conditions, and generally settle subsequent to the trade date. The repurchase program does not obligate the Company to acquire any specific number of shares or to acquire shares over any specified period of time.
Under this program as of March 31, 2022, the Company had repurchased 30.8 million shares at an aggregate purchase price of $1,401.0 million and had $99.0 million remaining available. During the three months ended March 31, 2022, the Company repurchased an aggregate of $217.3 million of common stock under this program.
In April 2022, the Company's Board of Directors approved a $500.0 million increase in share repurchase authorization.
|
||||||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|